ReviewMediastinum (Hong Kong, China)2026
Classification of mediastinal compartments: is separation of the superior mediastinum crucial?-a clinical practice review.
Review in Mediastinum (Hong Kong, China), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The division of the mediastinum into specific compartments is essential for identifying, characterizing, and managing mediastinal abnormalities. The current international standard is the three-compartment model proposed by the International Thymic Malignancy Interest Group (ITMIG), which divides the mediastinum into prevascular (anterior), visceral (middle), and paravertebral (posterior) compartments. This model has replaced the traditional four-compartment system, which included the superior mediastinum, due to its simplicity, familiarity, and clearly defined boundaries. However, given the superior mediastinum's unique anatomy and distinct pathology, it remains clinically reasonable to consider it separately. Continued clinical use of the term "superior mediastinum" has produced numerous conflicting definitions, while the Japanese Association for Research on the Thymus (JART) has recently proposed a computed tomography (CT)-based four-compartment model. Disease distribution in the superior mediastinum is dominated by thyroid goiters and neurogenic tumors, while the incidence of thymic epithelial tumors (TETs) in this region varies among studies. Surgery in the superior mediastinum is challenging due to its narrow space and the presence of major blood vessels and nerves. Operative complications frequently include Horner's syndrome. Furthermore, studies suggest that superior mediastinal thymomas may demonstrate more aggressive behavior and lower survival rates than thymomas in other locations. Establishing a clear, standardized definition of the superior mediastinum would resolve current inconsistencies and facilitate the accumulation of detailed clinical data on superior mediastinal lesions. This article focuses on the superior mediastinum and discusses its classification, clinical features, surgical approaches, treatment outcomes, and future perspectives.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.